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Introduction 
Diseases of the cardiovascular system and in particular those falling 
within the definition of ischaemic heart disease (IHO, coronary heart 
disease) covering a group of clinical syndromes that include angina 
pectoris, acute myocardial infarction (AM!), asymptomatic myocardial 
ischaemia and sudden ischaemic death, are together the commonest cause 
of death in Western society. 
Research into the detailed pathophysiology of IHO reveals more and 
more about the links between the mechanisms and the personal and 
environmental factors associated with such events as myocardial 
infarction and sudden ischaemic death. Malta, together with the UK, 
share the dubious distinction of having one of the highest mortality rates 
for cardiovascular diseases in Eurppe - 26.5% of the registered deaths in 
Malta were due to IHO. This high mortality is matched by a high 
prevalence of IHO, and the estimated risk factors (cigarette smoking, 
diabetes mellitus, raised serum total cholesterol concentration and blood 
pressure) are common in the Maltese archipelago. 
The treatment of patients with IHO is primarily focused on symptomatic 
relief i.e. reduction or abolition of angina pectoris (and its equivalents) 
and life prolongation. Nitrates are highly effective both in terminating 
acute attacks of angina pectoris and in the prophylaxis of symptomatic 
and asymptomatic myocardial ischaemia. 
Aims and Methodology 
Survey~ 
Prevalence of major risk factors in Maltese myocardial infarct patients 
'To determine the importance of blood cholesterol, smoking, hypertension, 
diabetes mellitus, alcohol consumption, family history, age, sex and 
social class as coronary risk factors, a study was made of admissions to 
the Coronary Care Unit of St Luke's Hospital - Malta for non-fatal AMI. 
Reports of MI which included at least two of the following 
manifesta tions: 
a) preceded by ~evere prolonged chest pain (>30 minutes) 
b) electrocardiographic evidence of myocardial infarction 
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c) cardiac enzyme changes (CPK, AST) associated with MI only were 
investigated. 
Categorization of diabetes meIIitus, blood pressure and cholesterol levels 
were based on WHO diagnostic criteria. 
Statistical analysis: Where applicable, the chi-squared test for trend 
was used. Other t-tests lacked sufficient data. 
Survey 2 
Maltese medical practitioners' approach and views to nitrate therapy 
In this postal survey, Maltese medical practitioners were questioned 
about their prescribing practices of nitrates as compared to other 
antianginals and newer nitrate formulations. Amongst other questions 
reviewed were: 
a) the clinical efficacy of nitrates 
b) incidence of nitrate side-effects 
c) main causes of nitrate therapy failure 
d) strategies for prevention of nitrate tolerance 
e) practitioner views regarding the nitrate controversy, mass 
screening for detection of ischaemia, and the pharmacists' role in 
treatment and prevention of ischaemia. 
Survey 3 
Maltese commumty pharmacists' role in nitrate therapy 
Practicing Maltese community pharmacists' (n==155) all over Malta and 
Gozo were questioned on the major advice sought by anginal/post-
infarction patients in the pharmacy setting, the nitrate formulations 
most commonly dispensed, any changes in prescribing practices of 
antianginals vis-a-vis newer nitrate delivery systems and calcium 
antagonists and whether the pharmacist considers himself to have an 
active role in the primary and secondary prevention of IHD. 
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Results and Discussion 
Survey! 
Prevalence of major risk factors in Maltese myocardial infarction patients 
Table 1 shows the distribution of risk factors among the male patients 
studied. Since there were only 2 female cases, sex was not investigated. 
Men over 60 years were 2.75 more likely to suffer a non-fatal AMI event 
than men aged 50-59 years; and 6.60 times more likely than man aged 40-
49. 
Raised serum cholesterol levels (>5.2mmol/l) constituted 64.1 % of cases, 
with borderline cholesterol levels taking a 51.3% share. The high 
prevalence of smokers (82.3%), ex or current, indicated that the effect of 
heavy smoking on IHO progression is long-term (31.4% previous and 
33.3% current heavy), and constitutes a major risk factor in AMI cases. 
The majority of male patients (54.9%) did not have IHO prior to 
infarction, possibly underlying the role of silent (asymptomatic) 
myocardial ischaemia (SMI) in atherosclerotic progression. SMI 
episodes are documented to be more frequent in diabetic and elderly 
subjects; 35.3% of the patients were diabetic, while 29.4% had impaired 
glucose tolerance. 
The higher the social standing of a person, the more likely one is 
conscious of, and has, positive attitudes to a healthy lifestyle. Such a 
trend was in fact seen to be the case in this study, with 47.9% of the 
patients being unskilled, this % decreasing with higher social class. 
Hypertension, especially elevated diastolic blood pressure (BP), 
accelerates existing atherosclerosis and initiates IHO in highly 
susceptible communities. Previous diagnosis of hypertension prior to the 
acute event constituted 35.3% of patients. However, it was not 
investigated whether the patients received antihypertensive treatment. 
Antihypertensi ve drugs (thiazides, propranolol) affect serum 
concentration of lfpids. 
It is widely accepted that a "bad" family history of IHO in a first-
degree relative, constitutes an important risk factor for IHO, and may 
multiply the risk up to 2-4 fold. 35.9% of the patients were found to have 
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Figure 1. Hypertension as a risk fac'tor: No. of patients 
plotted against age at 1st AMI (years), by blood-pressure 
. category. Values in brackets denote percentage (%) out 
of total No. of patients. n • 51 
a family disposition of IHO, determined by patient recall on prolective 
investigation. 
Epidemiological studies have consistently shown an apparent protective 
association between light to moderate alcohol consumption and IHO. In 
this study, male infarct patients were more likely to have been non-
drinkers (56.0%) than drinkers. Heavy drinkers were 1.8 more prevalent 
than moderate drinkers, while moderate drinkers were 5.6-fold less 
prevalent when compared to non-drinkers. On average, heavy drinkers 
have higher BP levels than others; this interela tion was not 
investigated. 
Table 2 shows results obtained in this study with those of the British 
Regional Heart Study, a prospective study aimed to determine the 
personal and environmental risk factors for IHO in Great Britain. 
Hypertension was 3 times more likely to be present in patients over 60 
years (Fig. 1) and 1.3 times more likely to be present in patients with no 
family history of IHO. The trend of an increasing proportion of infarct 
men who had no family history with increasing blood pressure was 0.05 
significant. 
Current heavy smoking constituted a major risk (33.3%) when compared to 
current and previous moderate smoking (9.8% and 7.8% respectively), and 
non-smokers (17.7%). The effect of cessation did not have an effect on the 
infarct outcome (Fig. 2), in that the years since cessation of smoking did 
not show an inverse relationship to the number of patients. Heavy 
smoking habits were more predominant in the 50-59 year age group (7/12 
patients). 22/33. patients over 60 years had current (8) or previous (14) 
heavy tobacco consumption. The trend of an increasing proportion of 
infarct men who had a family history with increasing tobacco 
consumption was 0.1 significant. 
The predominailt number of borderline cholesterol cases were aged over 60 
years (13/20 patients), while half of the patients aged 50-59 years (6/12 
patients) were borderline cases (Fig. 3). The majority of raised serum 
cholesterol (SCh) cases occurred in the 5th social class (12/24 patients 
investigated). The trend of an increasing proportion of infarct men who 
had high SCh level:; with decreasing social class was 0.5 significant. 
69.7% of patients aged over 60 years had raised serum glucose (sG) levels 
(23/33 investigated), with 30.4% of this category having diabetes (Fig. 
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Figure 3: Cholesterol (Serum) as a risk factor: No. of 
patients plotted against age at 1st AMI (Years) by blood 
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Figure 4: Serum glucose levels as a risk factor: No. of 
patients plotted against age at 1st AMI (Years) by serum 
glucose level categories etc. Values in brackets show 
percentage out of total No. of patients (n .. 51) 
4). 8/12 patients investigated between the age group 50-59 years also had 
raised se levels, with diabetes taking a 41.7% share in this age group. 
Diabetes was more common in the lower fifth class (12/23 patients 
investigated). The trend of an increasing proportion of infarct men who 
had a family history of IHD with increasing glucose levels was 0.5 
significant. 
Alcohol consumption was more predominant in the 60+yrs age group. The 
majority of drinkers lied in the lower fifth social class (10/22 drinkers 
investigated). 
Age and family history. The trend of an increasing proportion of infarct 
men who had no family history of IHD with increasing age was 0.25 
significant, underlying that there was a tendency of MI to becomE 
manifest at an early age in those with a family disposition. 
Survey 2 
The response rate was 49.1 % (106 responses out of 216). The majority of 
practitioners view nitrates as first line treatment for stable angina 
(67.9%) and prefer them to calcium antagonists for prophylactic 
management of angina (57.3% vs 42.7%). 89.2% agreed that treatment 
should be targeted at both silent (asymptomatic) and symptomatic 
episodes of ischaemia, however 42.2% do not agree with mass population 
screening of IHD, although they indicated that screening of high risk 
groups is feasible. Surprisingly, 51.3% of practitioners do not take 
measures to prevent or circumvent tolerance. The main risk factor (besides 
sex and age) associated with anginal development according to 
respondents' experience was smoking. 
The gross majority of medical practitioners (92.9%) supported other roles 
for the pharmacist besides patient referral. 
Survey 3 
The number of philrmacists responding was 30.3% (47 responses out of 155). 
570 
53.2% of pharmacists declared that ischaemic patients have never asked 
their advice on medical treatment of angina, while 46.8% answered in 
the affirmative. The most common advice sought regards correct usage of 
anti-anginals, followed by complaints re side-effects. Sublingual 
glyceryl trinitrate (GTN) was found to be the nitrate most dispensed for 
relief and prophylaxis of anginal pain (54.0%), while oral isosorbide 
dinitrate (ISDN) took the bigger share of the market for nitrates used for 
long-term prophylaxis (38.0%). The predominant change in prescribing 
practises, noted in 50.0% of respondents, was attributed to more calcium 
antagonists being prescribed as an alternative to nitrates. 87.2% of the 
pharmacists agree to more involvement, besides referraC in the treatment 
of angina, but only 29.8% agreed to participate in mass screening by non-
complex diagnostic tools (e.g. Reflotron, BP monitoring). The majority 
(70.2%) supported the advisory and educational role of pharmacists. 
Conclusion 
Survey 1 
The results obtained in this prolective study (except for hypertension) 
were comparable to the British Regional Heart Study (BRHS) suggesting 
similar lifestyles and environmental factors acting on myocardial infarct 
outcome in the Maltese and British populations. Both share amongst the 
highest mortality rates of IHD for Europe. 
The four main risk factors were found to be raised serum cholesterol 
levels, age, high tobacco consumption and low social class, suggesting 
that if dietary and anti-smoking campaigns are targeted at older men of 
low social standing, the incidence of non-fatal AMI will be drastically 
reduced. This does not minimize the importance of educating younger 
generations against unhealthy lifestyles to prevent the generation and 
progression of IHD; a role which pharmacists are in a prime position to 
execute. 
Survey 2 and 3 
Medical respondents commonly felt that nitrate therapy is still the first-
line therapy for angina. A positive mentality is being developed among 
practitioners regarding the importance of treating asymptomatic 
episodes, only recently proven effective, showing a clear interest of 
practitioners in the subject. Surprisingly, the majority do not agree with 
intermittant/pulse nitrate therapy, an important step in the 
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circumvention of nitrate tolerance, possibly denoting a possible role of 
pharmacists to inform practitioners better on this matter. 
The results obtained in both surveys re-inforces the belief that 
pharmacists have an important role as primary health educators and in 
the screening and evaluation of drug interactions. Moreover, the 
pharmacist has an important role in the primary prevention of IHD, 
being in a prime position to identify high risk groups and refer them to 
the practi tioner, besides giving educational ad vice abou t healthy 
lifestyles. The set-up of a cardiac unit established to screen any person, 
whether referred or not, who wishes to be checked for signs of ischaemia 
is proposed. 
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